14962511000001107: Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing methotrexate\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing methotrexate\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing methotrexate\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing pteridine\Product containing methotrexate\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing pteridine\Product containing methotrexate\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing pteridine\Product containing methotrexate\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing methotrexate\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing methotrexate\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing methotrexate\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

52267101000001116 Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

52267201000001111 Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Is a	Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has active ingredient	Methotrexate	false	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has specific active ingredient	Methotrexate	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 24 tablet 2 x 12 tablets	Has AMP	True	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 100 tablet 10 x 10 tablets	Has AMP	True	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 24 tablet	Is pack of	False	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 100 tablet	Is pack of	False	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 28 tablet	Is pack of	False	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 28 tablet	Has AMP	True	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 24 tablet	Has AMP	True	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) 100 tablet	Has AMP	True	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Orion Pharma (UK) Limited) 24 tablet 2 x 12 tablets (product)	Has AMP	True	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
52267101000001116	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
52267201000001111	Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module